CIK 0001356090
- Non-accelerated filer
- Smaller reporting company
PRECIGEN, INC.
Sign in to watch- Ticker
- PGEN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- Phone
- +1 301-556-9900
- Business address
- 20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
- Former names
- INTREXON CORP
- Open-market buys, last 90 days
- $24,662
- in 1 filing
- Open-market sales, last 90 days
- $2,345,145
- in 3 filings, $969K under 10b5-1 plans
Net −$2,320,483. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-31 | Sterling Rick L. Chief Financial Officer | Option exercise · Restricted Stock Units | −14,340 | 0 | ||
| 2020-03-23 | Lehr Donald P. Chief Legal Officer | Grant or award · Restricted Stock Units | −250,000 | 250,000 | ||
| 2020-03-23 | Perez Jeffrey Thomas SVP, IP Affairs | Grant or award · Restricted Stock Units | −250,000 | 250,000 | ||
| 2020-03-23 | Sabzevari Helen President and CEO | Grant or award · Restricted Stock Units | +500,000 | 500,000 | ||
| 2020-03-23 | Sterling Rick L. Chief Financial Officer | Grant or award · Restricted Stock Units | −250,000 | 250,000 | ||
| 2020-03-20 | KIRK RANDAL J Executive Chairman | Purchase | +420,336 | $2.72 | $1.1M | 10,511,973 |
| 2020-03-19 | KIRK RANDAL J Executive Chairman | Purchase | +500,000 | $1.87 | $935K | 10,011,973 |
| 2020-03-19 | KIRK RANDAL J Executive Chairman | Purchase | +79,664 | $2.05 | $163K | 10,091,637 |
| 2020-03-13 | Turley James S Director | Grant or award | +31,094 | $2.01 | $62K | 89,609 |
| 2020-03-13 | Turley James S Director | Grant or award · Restricted Stock Units | +62,189 | 62,189 | ||
| 2020-03-13 | Turley James S Director | Grant or award · Option to Purchase Common Stock (Right to Buy) | +96,324 | 96,324 | ||
| 2020-03-13 | SHAPIRO ROBERT B Director | Grant or award | +31,343 | $2.01 | $63K | 123,551 |
| 2020-03-13 | SHAPIRO ROBERT B Director | Grant or award · Restricted Stock Units | +62,189 | 62,189 | ||
| 2020-03-13 | SHAPIRO ROBERT B Director | Grant or award · Option to Purchase Common Stock (Right to Buy) | +96,324 | 96,324 | ||
| 2020-03-13 | MITCHELL DEAN J Director | Grant or award | +28,109 | $2.01 | $56K | 102,473 |
| 2020-03-13 | MITCHELL DEAN J Director | Grant or award · Restricted Stock Units | +62,189 | 62,189 | ||
| 2020-03-13 | MITCHELL DEAN J Director | Grant or award · Option to Purchase Common Stock (Right to Buy) | +96,324 | 96,324 | ||
| 2020-03-13 | KINDLER JEFFREY B Director | Grant or award | +34,328 | $2.01 | $69K | 143,071 |
| 2020-03-13 | KINDLER JEFFREY B Director | Grant or award · Restricted Stock Units | +62,189 | 62,189 | ||
| 2020-03-13 | KINDLER JEFFREY B Director | Grant or award · Option to Purchase Common Stock (Right to Buy) | +96,324 | 96,324 |
Page 45 of 52 · 1,021 trades